Unfortunately this is behind the Lexology paywall, but we thought we’d mention anyway as it is one of the few articles on the Topic to be authored from a UK perspective
Following a 40-year hiatus, research and development into the potential applications of psychedelic medicines has resurfaced. This article considers avenues to protect psychedelic companies’ intellectual property and their investment in research and development. Rising research activity has already led to an increase in patent filings for psychedelics in recent years, but this article also considers the need for a varied portfolio of IP rights, potentially utilising the protection offered to trade secrets.
